Cross-Framework Mapping

ISO/IEC 23894:2023vsPIC/S Guide to Good Manufacturing Practice for Medicinal Products

See exactly how ISO/IEC 23894:2023 controls map to PIC/S Guide to Good Manufacturing Practice for Medicinal Products. Pre-computed mappings, identified gaps, and coverage analysis.

13
Controls Mapped
72
Gaps Found
8%
Coverage

According to the TheArtOfService Compliance Knowledge Graph:

ISO/IEC 23894:2023 maps to PIC/S Guide to Good Manufacturing Practice for Medicinal Products with 8% coverage across 7 directly mapped controls. Analysis of 85 ISO/IEC 23894:2023 controls identifies 78 compliance gaps — primarily concentrated in Risk management process – ISO/IEC 23894:2023.

Source: TheArtOfService Knowledge Graph | 85 controls analysed | 718 frameworks | 332K+ cross-framework mappings

Control Mappings

Showing 13 of 13 mapped controls across 4 domains. Sign up to explore all 332K+ mappings across 718 frameworks.

Scope, Terms and References (Clauses 1-3)(6 mappings)

ISO23894-1Scope of AI Risk Management3 targets
PICSGMP-2Chapter 2: Personnel - Qualified Personnel, Key Responsibilities, Training
PICSGMP-5Chapter 5: Production Operations and Material Management
PICSGMP-7Chapter 7: Outsourced Activities and Supplier Management
ISO23894-3AI-Specific Terminology3 targets
PICSGMP-2Chapter 2: Personnel - Qualified Personnel, Key Responsibilities, Training
PICSGMP-5Chapter 5: Production Operations and Material Management
PICSGMP-7Chapter 7: Outsourced Activities and Supplier Management

Framework (Clause 5)(3 mappings)

ISO23894-5.1Leadership and Commitment
PICSGMP-1Chapter 1: Pharmaceutical Quality System (PQS) and Quality Risk Management
ISO23894-5.2AI Risk Management Integration
PICSGMP-1Chapter 1: Pharmaceutical Quality System (PQS) and Quality Risk Management
ISO23894-5.5Framework Evaluation
PICSGMP-1Chapter 1: Pharmaceutical Quality System (PQS) and Quality Risk Management

Process (Clause 6)(3 mappings)

ISO23894-6.2Scope, Context and Criteria3 targets
PICSGMP-2Chapter 2: Personnel - Qualified Personnel, Key Responsibilities, Training
PICSGMP-5Chapter 5: Production Operations and Material Management
PICSGMP-7Chapter 7: Outsourced Activities and Supplier Management

AI-Specific Risk Sources (Annex A)(1 mappings)

ISO23894-A.6AI System Security
PICSGMP-7Chapter 7: Outsourced Activities and Supplier Management

Related Comparisons

Other ISO/IEC 23894:2023 comparisons

Other PIC/S Guide to Good Manufacturing Practice for Medicinal Products comparisons

Stop Paying Consultants to Read Spreadsheets

AI-powered compliance intelligence across 718 frameworks — at a fraction of consulting costs.

$0/forever

Free

  • 718 framework browser
  • Cross-framework mappings (332K+)
  • 824 compliance assessments
  • 3 AI queries & searches per day
Get Started Free
Recommended
$49/month

Professional

  • Unlimited AI Compliance Advisory
  • Unlimited full-text search
  • Framework self-assessment
  • PDF, Excel & CSV exports
Start 7-Day Free Trial →

What are the key differences between ISO/IEC 23894:2023 and PIC/S Guide to Good Manufacturing Practice for Medicinal Products?

ISO/IEC 23894:2023 has 85 controls across its framework, while PIC/S Guide to Good Manufacturing Practice for Medicinal Products covers 9 controls. Direct mapping analysis identifies 7 overlapping controls (8% coverage). The frameworks diverge most significantly in Risk management process – ISO/IEC 23894:2023, where 17 ISO/IEC 23894:2023 controls have no direct PIC/S Guide to Good Manufacturing Practice for Medicinal Products equivalent.

How many controls map between ISO/IEC 23894:2023 and PIC/S Guide to Good Manufacturing Practice for Medicinal Products?

Of 85 total ISO/IEC 23894:2023 controls, 7 map directly to PIC/S Guide to Good Manufacturing Practice for Medicinal Products controls — representing 8% coverage. The remaining 78 controls represent compliance gaps requiring additional documentation or compensating controls to satisfy both frameworks simultaneously.

What are the compliance gaps when mapping ISO/IEC 23894:2023 to PIC/S Guide to Good Manufacturing Practice for Medicinal Products?

78 ISO/IEC 23894:2023 controls have no direct equivalent in PIC/S Guide to Good Manufacturing Practice for Medicinal Products. The highest concentration of gaps is in Risk management process – ISO/IEC 23894:2023 with 17 unmapped controls. These gaps represent areas where additional controls, policies, or documentation must be created to achieve compliance with both frameworks.

Which control domains have the most gaps between ISO/IEC 23894:2023 and PIC/S Guide to Good Manufacturing Practice for Medicinal Products?

The domain with the highest gap count is Risk management process – ISO/IEC 23894:2023 (17 gaps). Export the full domain-by-domain gap breakdown via the Professional tier to generate a prioritised remediation roadmap.

This platform provides educational compliance tools, not legal, regulatory, or professional compliance advice. Cross-framework mappings are AI-assisted interpretations and do not reproduce or replace official standards. Framework names and trademarks belong to their respective owners. Consult qualified professionals for your specific compliance requirements. See our Terms of Service.